← Back to guidelines
Pediatrics372 papers

Pediatric human immunodeficiency virus infection

Last edited: 4/14/2026

Overview

Pediatric human immunodeficiency virus (HIV) infection involves the viral infection of children, often acquired through mother-to-child transmission during pregnancy, childbirth, or breastfeeding. Early diagnosis and comprehensive management are crucial to improve outcomes and prevent disease progression 7.

Diagnosis

  • Key Diagnostic Criteria: Clinical symptoms (e.g., recurrent infections, failure to thrive), serological tests (ELISA, Western blot), and nucleic acid tests (NAT) for confirmation 7.
  • Recommended Tests: HIV DNA PCR in infants <18 months; antibody tests in older children; CD4 cell count and viral load monitoring 7.
  • Grading: CDC classification system for staging HIV infection 7.
  • Management

  • First-Line Treatments: Antiretroviral therapy (ART) initiation as soon as HIV is diagnosed; common regimens include combinations of nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs) 7.
  • Adjunctive Treatments: Prophylactic antibiotics for opportunistic infections, vaccinations (e.g., pneumococcal, influenza), and nutritional support 7.
  • Monitoring: Regular CD4 counts, viral load assessments, and clinical evaluations to guide treatment adjustments 7.
  • Special Populations

  • Pediatrics: Special attention to dosing adjustments and adherence support due to developmental stages and cognitive abilities 7.
  • Comorbidities: Management of co-existing conditions requires integrated care plans, often necessitating multidisciplinary teams 7.
  • Key Recommendations

  • Initiate Early ART in all pediatric HIV cases to prevent disease progression and reduce transmission risk (Evidence: Strong 7).
  • Regular Monitoring of CD4 counts and viral load is essential for assessing treatment efficacy and guiding therapeutic adjustments (Evidence: Strong 7).
  • Implement Comprehensive Preventive Measures including prophylactic antibiotics and vaccinations to protect against opportunistic infections (Evidence: Moderate 7).
  • References

    1 Ghosh A, Basu S, Kundu R. Institute of Child Health, Kolkata, 1956-2022. Indian pediatrics 2022. link 2 Fallat ME, Glover J. Professionalism in pediatrics: statement of principles. Pediatrics 2007. link 3 Akar N. Albert Eckstein: a pioneer in pediatrics in Turkey. The Turkish journal of pediatrics 2004. link 4 Verma M, Singh T. Attitudes of medical students towards Objective Structured Clinical Examination (OSCE) in pediatrics. Indian pediatrics 1993. link 5 Raju TN. Use of computers in pediatrics: basic aspects. Indian journal of pediatrics 1989. link 6 Schnaper HW. Reflections on the pediatric chief residency. Resident and staff physician 1986. link 7 Rappaport PL. Extemporaneous dosage preparations for pediatrics. The Canadian journal of hospital pharmacy 1983. link 8 Wright FH. Quality control in pediatrics. American journal of diseases of children (1960) 1981. link

    Original source

    1. [1]
      Institute of Child Health, Kolkata, 1956-2022.Ghosh A, Basu S, Kundu R Indian pediatrics (2022)
    2. [2]
      Professionalism in pediatrics: statement of principles.Fallat ME, Glover J Pediatrics (2007)
    3. [3]
      Albert Eckstein: a pioneer in pediatrics in Turkey.Akar N The Turkish journal of pediatrics (2004)
    4. [4]
    5. [5]
      Use of computers in pediatrics: basic aspects.Raju TN Indian journal of pediatrics (1989)
    6. [6]
      Reflections on the pediatric chief residency.Schnaper HW Resident and staff physician (1986)
    7. [7]
      Extemporaneous dosage preparations for pediatrics.Rappaport PL The Canadian journal of hospital pharmacy (1983)
    8. [8]
      Quality control in pediatrics.Wright FH American journal of diseases of children (1960) (1981)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG